Phase 1/2
Showing 9976 - 10000 of >10,000
Gastric Cancer Trial in Worldwide (5-Fluorouracil, Ipatasertib, Leucovorin)
Anesthesia, Local Trial in New York (Lidocaine 2% Injectable Solution, Lidocaine 1% Injectable Solution, Bupivacaine 0.25%
Enrolling by invitation
- Anesthesia, Local
- Lidocaine 2% Injectable Solution, Lidocaine 1% Injectable Solution, Bupivacaine 0.25% injectable solution, Bupivacaine 0.5% injectable solution, saline, no injection -- Followed by IL 20% IV Bolus
- Lidocaine 2% Injectable Solution, Lidocaine 1% Injectable Solution, Bupivacaine 0.25% injectable solution, Bupivacaine 0.5% injectable solution, saline, no injection -- Followed by Saline Bolus
-
New York, New YorkHospital of Special Surgery
Dec 1, 2022
Diabetes, Type 2, Chronic Kidney Disease Trial in Worldwide (Semaglutide, Placebo (Semaglutide))
Recruiting
- Diabetes Mellitus, Type 2
- Chronic Kidney Disease
- Semaglutide
- Placebo (Semaglutide)
-
Tucson, Arizona
- +33 more
Jan 17, 2023
Idiopathic Pulmonary Fibrosis Trial in Lincoln (BBT-877, Single dose, Placebo group, BBT-877, Multiple doses)
Completed
- Idiopathic Pulmonary Fibrosis
- BBT-877, Single dose
- +2 more
-
Lincoln, NebraskaCelerion
Jan 15, 2020
Mild Traumatic Brain Injury, Functional Neurological Disorder Trial in Canada (Cognitive Behavioural Therapy (CBT), Cognitive
Recruiting
- Mild Traumatic Brain Injury
- Functional Neurological Disorder
- Cognitive Behavioural Therapy (CBT)
- Cognitive Rehabilitation
-
North Vancouver, British Columbia, Canada
- +9 more
Nov 29, 2022
Interstitial Lung Disease, Chronic Kidney Diseases Trial in Adelaide (AD-214, Placebo)
Not yet recruiting
- Interstitial Lung Disease
- Chronic Kidney Diseases
- AD-214
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research Pty Ltd
Jun 20, 2023
Congenital Myotonic Dystrophy Trial in Worldwide (Tideglusib, Placebo)
Recruiting
- Congenital Myotonic Dystrophy
- Tideglusib
- Placebo
-
Little Rock, Arkansas
- +14 more
Aug 11, 2022
Barrett Esophagus Trial in Ann Arbor (KSP/QRH dimer)
Recruiting
- Barrett Esophagus
- KSP/QRH dimer
-
Ann Arbor, MichiganUniversity of Michigan
Jan 5, 2022
Healthy Trial in Dallas (Rosuvastatin, Selpercatinib)
Not yet recruiting
- Healthy
-
Dallas, TexasLabcorp Clinical Research LP
Jun 8, 2023
Healthy Volunteer, Becker Muscular Dystrophy Trial in San Antonio (EDG-5506, Placebo)
Completed
- Healthy Volunteer
- Becker Muscular Dystrophy
- EDG-5506
- Placebo
-
San Antonio, TexasWorldwide Clinical Trials
Jun 27, 2022
Advanced Malignancies Trial in Beijing (IBI939, IBI939+ Sintilimab)
Active, not recruiting
- Advanced Malignancies
- IBI939
- IBI939+ Sintilimab
-
Beijing, ChinaPeking University Cancer Hospital & Institute
Oct 4, 2022
Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,
Recruiting
- Gynecologic Cancer
- +11 more
- Neoantigen specific TCR-T cell drug product
- Aldesleukin (IL-2)
-
Houston, TexasMD Anderson Cancer Center
Jul 27, 2022
Facial Paralysis Trial in United States (NTX-001)
Recruiting
- Facial Paralysis
- NTX-001
-
Indianapolis, Indiana
- +3 more
Sep 28, 2022
Neonatal Opioid Withdrawal Syndrome Trial in Las Vegas, Philadelphia (CHF6563, Morphine, CHF6563 matched )
Terminated
- Neonatal Opioid Withdrawal Syndrome
- CHF6563
- +3 more
-
Las Vegas, Nevada
- +1 more
Mar 11, 2022
Healthy Trial in Brussels (Sinsunatovir, Bitrex)
Recruiting
- Healthy
- Sinsunatovir
- Bitrex
-
Brussels, Bruxelles-capitale, Région DE, BelgiumPfizer Clinical Research Unit - Brussels
Aug 15, 2023
Corneal Epithelial Degeneration Trial in Cypress (TTHX1114(NM141) Ophthalmic Solution)
Recruiting
- Corneal Epithelial Degeneration
- TTHX1114(NM141) Ophthalmic Solution
-
Cypress, CaliforniaTrefoil Clinical Site #132
Mar 3, 2023
Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma Trial in
Active, not recruiting
- Stage I Mantle Cell Lymphoma
- +4 more
- Autologous Hematopoietic Stem Cell Transplantation
- +8 more
-
Buffalo, New York
- +1 more
Mar 9, 2022
Colorectal Cancer Trial in Chengdu (Lidocaine Hydrochloride 2% Injection Solution, 0.9% NaCl)
Recruiting
- Colorectal Cancer
- Lidocaine Hydrochloride 2% Injection Solution
- 0.9% NaCl
-
Chengdu, Sichuan, ChinaWest China Hospital
Jun 7, 2022
Stroke Trial in Kaposvár (Robot, Fizio, EXE1)
Active, not recruiting
- Stroke
- Robot
- +4 more
-
Kaposvár, Somogy, HungaryDr. Tollár József
Aug 2, 2023
Dry Eye Trial in Norfolk (RU-101)
Completed
- Dry Eye
- RU-101
-
Norfolk, VirginiaVirginia Eye Consultants
Sep 9, 2019
Redundant Prepuce Trial in Toronto (2-octyl cyanoacrylate)
Recruiting
- Redundant Prepuce
- 2-octyl cyanoacrylate
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Oct 8, 2021
Breast Cancer,Her2 Positive Trial in Zhengzhou (Albumin binding paclitaxel+ trastuzumab+ patuzumab, Docetaxel+ carboplatin+
Recruiting
- Breast Cancer,Her2 Positive
- Albumin binding paclitaxel+ trastuzumab+ patuzumab
- Docetaxel+ carboplatin+ trastuzumab + patuzumab
-
Zhengzhou, Henan, ChinaHenan cancer hospital
Nov 19, 2022